Tirzepatide

Dual GIP/GLP-1 therapy for patients who need more than a GLP-1 alone.

$199/year once approved, plus a one-time $49 consultation fee. Medication is billed separately, at the lowest price we can source from a reputable compounding pharmacy.

Who it's for

Insulin resistance
Limited response to semaglutide
Higher starting BMI

What to expect

Same eligibility screening as semaglutide
Monthly check-ins during titration

Safety notes

Same thyroid and pancreatitis exclusions as other incretin therapies

Prescribing is not guaranteed

Completing an intake is a request for evaluation, not an order. A board-certified physician or provider reviews every submission and may approve treatment, request more information or labs, suggest a different option, or decline if it isn't appropriate for you.